CONTROL OF MONOCYTE CHEMOTACTIC FACTOR EXPRESSION
CONTROL OF MONOCYTE CHEMOTACTIC FACTOR EXPRESSION
批准号:
2184160
负责人:
RODNEY S KAWAHARA
金额:
$10.28万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-02-01 至 1997-01-31
关键词:
DNA binding protein DNA footprinting RNA biosynthesis RNase protection assay Rous sarcoma virus animal tissue chemoattractants chloramphenicol acetyltransferase enzyme induction /repression gel mobility shift assay gene deletion mutation gene expression genetic enhancer element genetic promoter element genetic regulation glucocorticoids hormone regulation /control mechanism molecular cloning monocyte nucleolus oligonucleotides platelet derived growth factor polymerase chain reaction protein purification reporter genes simian virus 40 somatotropin thymidine kinase tissue /cell culture transcription factor transfection
中文摘要
这个项目的长期目标是了解细胞内的
细胞因子和激素调节转录的机制
否则就是静止的基因。血小板对成纤维细胞的刺激作用
衍生生长因子(PDGF)导致血管内皮细胞
我是吉恩。乙脑编码一种单核细胞的小鼠同源蛋白
趋化蛋白-I(MCP-1)是一个不断增长的超家族成员
相关的可诱导细胞因子。JE/MCP-1已被确定为主要
来自平滑肌细胞的单核细胞特异性趋化因子和各种
肿瘤细胞系,并可能在肿瘤的发病机制中发挥重要作用。
动脉粥样硬化,在伤口愈合和炎症过程中。强有力的
抗炎糖皮质激素抑制PDGF诱导的乙脑
具有与其药理一致的药效等级顺序的基因
作为一种消炎剂。DNA的缺失和突变
乙脑基因两侧或内部的序列将被用来识别关键字
PDGF诱导转录的调控序列
糖皮质激素的抑制作用。结合转录因子
将通过足迹和凝胶来表征这些序列
发育迟缓分析。这些因子的大规模提纯将是
他们的基因将被克隆。实验旨在
糖皮质激素介导的四种模型机制辨析
转录抑制被提出。为了进一步深入研究
乙脑转录活性的正负调节,
提出了以下具体目标:
特异性目标1:乙脑启动子缺失突变体的构建与分析
识别转录增强子区(PDGF反应元件)
负责PDGF诱导的基因表达。
具体目标2:定位和确定负责
糖皮质激素介导的转录抑制。
具体目标3:鉴定和鉴定转录因子
识别和结合PDGF反应元件和糖皮质激素介导的
转录抑制物区。
具体目标4:将亲缘关系、数目和可能的亲属联系起来
转录因子DNA与转录因子水平结合的位置效应
PDGF诱导JE表达和糖皮质激素介导的抑制。
特定目标5:纯化和克隆转录因子
参与PDGF对JE基因的正向调控
糖皮质激素的负性调节。
英文摘要
The long term goal of this project is to understand the intracellular
mechanism by which cytokines and hormones regulate the transcription of
otherwise quiescent genes. Stimulation of fibroblasts with Platelet-
derived growth factor (PDGF) results in the increased transcription of the
JE gene. JE encodes a protein in which is the murine homolog of Monocyte
Chemotactic Protein-I (MCP-1) and is a member of a growing superfamily of
related inducible cytokines. JE/MCP-1 has been identified as the major
monocyte specific chemotactic factor from smooth muscle cells and various
tumor cell lines, and may play an important role in the pathogenesis of
atherosclerosis, in wound healing and in the inflammatory process. Potent
anti-inflammatory glucocorticoids inhibits the PDGF induction of the JE
gene with the same rank order of potency consistent with its pharmacology
as an anti-inflammatory agent. Deletions and mutations of the DNA
sequences flanking or within the JE gene will be made to identify key
regulatory sequences responsible for the transcriptional induction by PDGF
and the repression by glucocorticoids. Transcriptional factors which bind
to these sequences will be characterized by footprinting and gel
retardation assays. Large scale purification of these factors will be
attempted and their genes will be cloned. Experiments designed to
distinguish between four model mechanisms of glucocorticoid mediated
transcriptional repression are proposed. To further the study of the
positive and negative regulation of JE transcriptional activity, the
following specific aims are proposed:
Specific Aim 1: Construction and analysis of JE promotor deletion mutants
to identify transcriptional enhancer regions (PDGF response elements) which
are responsible for PDGF induced gene expression.
Specific Aim 2: Locate and identify DNA repressor regions responsible for
the glucocorticoid mediated transcriptional repression.
Specific Aim 3: To identify and characterize transcription factors which
recognize and bind to PDGF response elements and to glucocorticoid mediated
transcriptional repressor regions.
Specific Aim 4: To correlate the affinity, number and possible relative
positional effects of transcription factor DNA binding with the level of
PDGF induced JE expression and glucocorticoid mediated repression.
Specific Aim 5: To purify and clone transcription factors which are
involved in the positive regulation of the JE gene by PDGF and in the
negative regulation by glucocorticoids.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONTROL OF MONOCYTE CHEMOTACTIC FACTOR EXPRESSION
-
批准号:2184161
-
项目类别:
-
资助金额:$11.04万
-
财政年份:1992
-
负责人:RODNEY S KAWAHARA
-
依托单位:
CONTROL OF MONOCYTE CHEMOTACTIC FACTOR EXPRESSION
-
批准号:2184162
-
项目类别:
-
资助金额:$11.81万
-
财政年份:1992
-
负责人:RODNEY S KAWAHARA
-
依托单位:
CONTROL OF MONOCYTE CHEMOTACTIC FACTOR EXPRESSION
-
批准号:3468650
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1992
-
负责人:RODNEY S KAWAHARA
-
依托单位:
CONTROL OF MONOCYTE CHEMOTACTIC FACTOR EXPRESSION
-
批准号:3468649
-
项目类别:
-
资助金额:$8.6万
-
财政年份:1992
-
负责人:RODNEY S KAWAHARA
-
依托单位:
海外基金